e-learning
resources
Virtual 2020
Pre-Congress Content
COPD : inhaled corticosteroids, bronchodilators and eosinophils
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Stability of sputum and blood eosinophil levels in COPD
A. Beech (Manchester, United Kingdom), S. Lea (Manchester, United Kingdom), U. Kolsum (Manchester, United Kingdom), N. Jackson (Manchester, United Kingdom), P. Hitchen (Manchester, United Kingdom), S. Wolosianka (Manchester, United Kingdom), D. Singh (Manchester, United Kingdom)
Source:
Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session:
COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session type:
E-poster session
Number:
3250
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Beech (Manchester, United Kingdom), S. Lea (Manchester, United Kingdom), U. Kolsum (Manchester, United Kingdom), N. Jackson (Manchester, United Kingdom), P. Hitchen (Manchester, United Kingdom), S. Wolosianka (Manchester, United Kingdom), D. Singh (Manchester, United Kingdom). Stability of sputum and blood eosinophil levels in COPD. 3250
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Reproducibility of COPD blood eosinophil counts
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Role of sputum eosinophil levels in the assessment of asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004
Blood eosinophil as a biomarker in COPD
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Cytokine profile of blood and sputum in COPD exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 575s
Year: 2006
Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood
Source: Eur Respir J 2005; 26: Suppl. 49, 625s
Year: 2005
Dissosiation between eosinophils in sputum and blood of asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002
The reproducibility of COPD blood eosinophil counts
Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018
Year: 2018
Cytokines profile of blood and sputum in COPD exacerbation
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Cytokines profile of blood and sputum in COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 279s
Year: 2003
Cytokine profile of blood and sputum at infectional COPD exacerbation
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Characteristic of cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
Source: Eur Respir J 2016; 47:1562-1564
Year: 2016
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Relationship between blood eosinophil levels and severity of COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept